CONTEXT: Hepatitis C and diabetes represent important health problems globally. The new-onset diabetes after transplantation is a particular entity that appears due to the use of immunosuppression among transplanted patients. OBJECTIVE: We aim to describe the clinical and biological aspects of severe hyperglycemia in a kidney transplant recipient undergoing Interferon-free therapy for chronic hepatitis C, discussing the interference of different factors with the glucose metabolism. DESIGN: The occurrence of diabetes in a patient with history of renal transplantation and Interferon-free treated hepatitis C was studied from both clinical and paraclinical points of view. SUBJECTS AND METHODS: When presenting to the hospital, extensive blood tests were performed on the patient, revealing significant hyperglycemia and an elevated level of blood tacrolimus. Creatinine clearance was calculated. ECG presented T-wave alterations. Intensive insulin protocol was applied, the case being managed in a multidisciplinary approach. RESULTS: Blood glucose and tacrolimus were slowly normalized, under therapy. The antiviral treatment was continued, with the achievement of sustained virologic response. CONCLUSIONS: Diabetes mellitus can have many causes, hepatitis C and transplantation both having an impact on glucose metabolism. The association of the three entities should be carefully managed, due to its enhancing effect on morbidity and mortality.
CONTEXT: Hepatitis C and diabetes represent important health problems globally. The new-onset diabetes after transplantation is a particular entity that appears due to the use of immunosuppression among transplanted patients. OBJECTIVE: We aim to describe the clinical and biological aspects of severe hyperglycemia in a kidney transplant recipient undergoing Interferon-free therapy for chronic hepatitis C, discussing the interference of different factors with the glucose metabolism. DESIGN: The occurrence of diabetes in a patient with history of renal transplantation and Interferon-free treated hepatitis C was studied from both clinical and paraclinical points of view. SUBJECTS AND METHODS: When presenting to the hospital, extensive blood tests were performed on the patient, revealing significant hyperglycemia and an elevated level of blood tacrolimus. Creatinine clearance was calculated. ECG presented T-wave alterations. Intensive insulin protocol was applied, the case being managed in a multidisciplinary approach. RESULTS: Blood glucose and tacrolimus were slowly normalized, under therapy. The antiviral treatment was continued, with the achievement of sustained virologic response. CONCLUSIONS: Diabetes mellitus can have many causes, hepatitis C and transplantation both having an impact on glucose metabolism. The association of the three entities should be carefully managed, due to its enhancing effect on morbidity and mortality.
Authors: Phuong-Thu T Pham; Phuong-Chi T Pham; Gerald S Lipshutz; Alan H Wilkinson Journal: Endocrinol Metab Clin North Am Date: 2007-12 Impact factor: 4.741
Authors: Roy D Bloom; Vinaya Rao; Francis Weng; Robert A Grossman; Debbie Cohen; Kevin C Mange Journal: J Am Soc Nephrol Date: 2002-05 Impact factor: 10.121
Authors: Khuong B Nguyen; Wendy T Watford; Rachelle Salomon; Sigrun R Hofmann; Gary C Pien; Akio Morinobu; Massimo Gadina; John J O'Shea; Christine A Biron Journal: Science Date: 2002-09-20 Impact factor: 47.728
Authors: Robert S Woodward; Mark A Schnitzler; Jack Baty; Jeffrey A Lowell; Lissa Lopez-Rocafort; Seema Haider; Thasia G Woodworth; Daniel C Brennan Journal: Am J Transplant Date: 2003-05 Impact factor: 8.086
Authors: Xenia Bacinschi; Adriana Mercan-Stanciu; Letitia Toma; Anca Zgura; Nicolae Bacalbasa; Chen-Peng Ifrim; Camelia Diaconu; Laura Iliescu; Radu Valeriu Toma Journal: In Vivo Date: 2022 May-Jun Impact factor: 2.406
Authors: Silviu Guler-Margaritis; Adriana Mercan-Stanciu; Letitia Toma; Daniel Rusie; Teodora Isac; Mihai Dodot; Anca Zgura; Nicolae Bacalbasa; Bogdan Haineala; Dumitru Cristinel Badiu; Dragos Serban; Elena Laura Iliescu Journal: In Vivo Date: 2021 Nov-Dec Impact factor: 2.155